Filing Flows › Aspira Women's Health (AWHL) › Q1 2026
Aspira Women's Health (AWHL) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Aspira Women's Health (AWHL) reported revenue of $2.0M for the first quarter 2026 (Q1 2026), -14% from a year earlier and -12% from the quarter before. Operating margin was -112.0%, net earnings $676K (34.4% of revenue).
Aspira Women's Health, Q1 2026: revenue $2.0M (-14% year over year), operating margin -112.0%, net earnings $676K, operating cash flow −$359K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | -12% | -14% |
| Operating profit | −$2.2M | — | — |
| Net earnings | $676K | — | — |
| Operating cash flow | −$359K | — | — |
What changed
Revenue was $2.0M in Q1 2026, down 14% year over year and down 12% from the previous quarter.
Gross margin was 54.4%, down 14.0 points from a year earlier. Operating costs exceeded revenue by $2.2M, an operating margin of -112.0%. Operating expenses fell 32% while revenue fell 14%. The fastest-growing cost line was Research & development (+26%). Net earnings were $676K. The effective tax rate was 0.0%. Non-operating items added $2.9M, 426% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$359K. Non-cash charges added back $40K of depreciation and amortization and $42K of share-based compensation. Working capital and other items used $1.1M.
Questions
What was Aspira Women's Health's revenue in the first quarter 2026?
Aspira Women's Health (AWHL) reported revenue of $2.0M for the first quarter 2026 (Q1 2026), -14% from a year earlier and -12% from the quarter before.
Was Aspira Women's Health profitable in the first quarter 2026?
Operating loss was $2.2M (-112.0% of revenue) and net earnings $676K.